Evaluation of Human Efficacy of SOD Like Super Drink

March 14, 2024 updated by: TCI Co., Ltd.
To assess the efficacy of SOD like Super Drink on anti-oxidant capacity, immuno regulation and skin for human

Study Overview

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Taichung City, Taiwan, 406040
        • Recruiting
        • China Medical University of department of cosmeceutics
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • healthy adults aged between 30-65 years old

Exclusion Criteria:

  • Subjects who have known cosmetic, drug or food allergies, difficulty in digestive tract absorption or disorder
  • Patients with diseases of the skin, liver, kidney.
  • Female who is pregnant or nursing or planning to become pregnant during the course of the study.
  • Received facial laser therapy, chemical peeling or UV overexposure (> 3 hr/week) in the past 4 weeks.
  • Students who are currently taking courses taught by the principal investigator of this trial.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: placebo drink
consume 1 bottle per day
Experimental: SOD like Super Drink
consume 1 bottle per day
Other Names:
  • AVON SOD like Super Drink

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the volume of skin wrinkles
Time Frame: Volume change from Baseline skin wrinkles at 8 weeks
IRV full-face skin analyzer was utilized to measure skin wrinkles. Units: arbitrary units
Volume change from Baseline skin wrinkles at 8 weeks
the roughness of skin texture
Time Frame: Rating skin roughness from Baseline skin texture at 8 weeks
IRV full-face skin analyzer was utilized to measure skin texture. Units: arbitrary units
Rating skin roughness from Baseline skin texture at 8 weeks
the change of skin elasticity
Time Frame: Change from Baseline skin elasticity at 8 weeks
Cutometer® was utilized to measure skin elasticity. Units: arbitrary units
Change from Baseline skin elasticity at 8 weeks
the change of Total Anti-oxidative Capacity (TAC) of blood
Time Frame: Change from Baseline TAC at 8 weeks
venous blood was sampled to measure TAC
Change from Baseline TAC at 8 weeks
the change of Superoxide Dismutase (SOD) of blood
Time Frame: Change from Baseline SOD at 8 weeks
venous blood was sampled to measure SOD
Change from Baseline SOD at 8 weeks
the change of Glutathione S-transferase (GST) of blood
Time Frame: Change from Baseline GST at 8 weeks
venous blood was sampled to measure GST
Change from Baseline GST at 8 weeks
the change of Glutathione (GSH) of blood
Time Frame: Change from Baseline GSH at 8 weeks
venous blood was sampled to measure GSH
Change from Baseline GSH at 8 weeks
the change of Malondialdehyde (MDA) of blood
Time Frame: Change from Baseline MDA at 8 weeks
venous blood was sampled to measure MDA
Change from Baseline MDA at 8 weeks
the change of immune-related cytokines of blood
Time Frame: Change from Baseline immune-related cytokines at 8 weeks
venous blood was sampled to measure immune-related cytokines
Change from Baseline immune-related cytokines at 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the change of skin surface hydration
Time Frame: Change from Baseline skin surface hydration at 8 week
Corneometer® CM 825 was utilized to measure skin surface hydration. Units: arbitrary units
Change from Baseline skin surface hydration at 8 week
the change of skin Transepidermal Water Loss (TEWL)
Time Frame: Change from Baseline TEWL at 8 week
Tewameter® TM 300 was utilized to measure TEWL. Units: arbitrary units
Change from Baseline TEWL at 8 week
the change of Skin Melanin Index
Time Frame: Change from Baseline skin Melanin Index at 8 week
Mexameter® MX 18was utilized to measure Melanin Index. Units: arbitrary units
Change from Baseline skin Melanin Index at 8 week
the change of Skin Erythema Index
Time Frame: Change from Baseline skin Erythema Index at 8 week
Mexameter® MX 18was utilized to measure skin Erythema Index. Units: arbitrary units
Change from Baseline skin Erythema Index at 8 week

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
The change of liver function biomarkers (AST, ALT) of blood
Time Frame: Change from Baseline liver function biomarkers at 8 weeks
Venous blood was sampled to measure liver function biomarkers
Change from Baseline liver function biomarkers at 8 weeks
The change of renal function biomarkers (creatinine, BUN) of blood
Time Frame: Change from Baseline renal function biomarkers at 8 weeks
Venous blood was sampled to measure renal function biomarkers
Change from Baseline renal function biomarkers at 8 weeks
The change of self-assessment skin condition and immuno condition
Time Frame: Change from Baseline skin condition and immunol condition at 8 weeks
A self-assessment questionnaire was collected to evaluate skin condition and immunol condition,As for the evalutation of skin condition ,the higher score the better;As for evaluation of immunol condition , the higher score the worse
Change from Baseline skin condition and immunol condition at 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Hsiu-Mei Chiang, China Medical University of department of cosmeceutics

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2024

Primary Completion (Estimated)

October 31, 2024

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

February 29, 2024

First Submitted That Met QC Criteria

March 14, 2024

First Posted (Actual)

March 21, 2024

Study Record Updates

Last Update Posted (Actual)

March 21, 2024

Last Update Submitted That Met QC Criteria

March 14, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • CMUH112-REC3-175

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dermatology

Clinical Trials on placebo drink

3
Subscribe